Li, Shuo
Zeng, Weihua
Li, Wenyuan
Liu, Chun-Chi
Zhou, Yonggang
Ni, Xiaohui
Stackpole, Mary L.
Yeh, Angela H.
Melehy, Andrew
Lu, David S.
Raman, Steven S.
Hsu, William
Mishra, Lopa
Shetty, Kirti
Tran, Benjamin
Yokomizo, Megumi
Ahuja, Preeti
Zhu, Yazhen
Tseng, Hsian-Rong
Aberle, Denise R.
Agopian, Vatche G.
Han, Steven-Huy B.
French, Samuel W.
Dubinett, Steven M.
Zhou, Xianghong Jasmine
Wong, Wing Hung
Funding for this research was provided by:
National Cancer Institute (U01CA285010)
National Cancer Institute (R01CA246329)
National Cancer Institute (U01CA230705)
V Foundation
Connie Frank Foundation
National Human Genome Research Institute (R01HG010359)
Article History
Received: 14 May 2025
Accepted: 9 February 2026
First Online: 25 February 2026
Declarations
:
: The institutional review board (IRB) of the University of California at Los Angeles approved this study (IRB#19-000618, IRB#19-000230, IRB#19-001488, IRB#16-000659), and our research complies with all relevant ethical regulations. All participants gave their written informed consent.
: Not applicable.
: X.J.Z., W.H.W., and W.L. are co-founders and board members of EarlyDiagnostics, Inc. X.J.Z. has an executive leadership position at EarlyDiagnostics, Inc. M.L.S, X.N., and C.-C.L. are employees of EarlyDiagnostics,Inc and S.M.D. was a scientific advisor to EarlyDiagnostics, Inc. X.J.Z., W.L., and W.H.W. are stockholders of EarlyDiagnostics, Inc. M.L.S, W.Z., S.L., C.-C.L., Y.Z., X.N. have stock options with EarlyDiagnostics, Inc. S.L., W.L., W.Z., and Y.Z. are consultants for EarlyDiagnostics, Inc. X.J.Z., C.-C.L. X.N., M.L.S, and W.Z. are inventors on a patent application submitted by the Regents of the University of California and EarlyDiagnostics, Inc. (Patent No. WO2023283591A2). The other authors have no competing interests to declare.